a 68930 has been researched along with oxidopamine in 5 studies
| Studies (a 68930) | Trials (a 68930) | Recent Studies (post-2010) (a 68930) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 63 | 2 | 19 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | a 68930 (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breese, GR; Criswell, HE; Jensen, KF; Johnson, KB; Mueller, RA; Simson, PE | 1 |
| Ackerman, M; Artman, L; Asin, KE; Bednarz, L; Briggs, C; Britton, DR; DeNinno, MP; MacKenzie, R; Schoenleber, R; Trugman, JM | 1 |
| Britton, DR; Curzon, P; Kebabian, JW | 1 |
| Asin, KE; DeNinno, MP; Kebabian, JW; MacKenzie, R; Schoenleber, R | 1 |
| Asin, K; Briggs, C; Britton, DR; DeNinno, M; Kebabian, JW; MacKenzie, RG; McKelvy, JF; Schoenleber, R | 1 |
1 review(s) available for a 68930 and oxidopamine
| Article | Year |
|---|---|
A68930: a potent and specific agonist for the D-1 dopamine receptor.
Topics: Animals; Benzopyrans; Chromans; Corpus Striatum; Denervation; Dopamine; Hydroxydopamines; Oxidopamine; Parkinson Disease; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Stereoisomerism | 1990 |
4 other study(ies) available for a 68930 and oxidopamine
| Article | Year |
|---|---|
Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Brain Chemistry; Chromans; Dopamine Agents; Dose-Response Relationship, Drug; Female; Motor Activity; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior | 1992 |
A68930: a potent agonist selective for the dopamine D1 receptor.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Binding Sites; Carps; Chromans; Deoxyglucose; Dopamine Agents; Haloperidol; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Seizures; Substantia Nigra; Tumor Cells, Cultured | 1991 |
Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Chromans; Denervation; Dopamine Agents; Levodopa; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1991 |
(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist.
Topics: Animals; Benzazepines; Binding, Competitive; Chromans; Dopamine Agents; Hydroxydopamines; Molecular Structure; Oxidopamine; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Stereoisomerism | 1990 |